---
document_datetime: 2025-04-10 11:47:15
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/kaletra-epar-all-authorised-presentations_en.pdf
document_name: kaletra-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0251727
conversion_datetime: 2025-12-28 14:52:30.046943
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength            | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size                     |
|------------------|-------------------|---------------------|-----------------------|---------------------------|-----------------------|---------------------------|-------------------------------|
| EU/1/01/172/003  | Kaletra           | 80 mg/ml / 20 mg/ml | Oral solution         | Oral use                  | bottle (PET)          | 60 ml                     | 5 bottles + 5 x 5 ml syringes |
| EU/1/01/172/004  | Kaletra           | 200 mg / 50 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE)         |                           | 120 tablets                   |
| EU/1/01/172/006  | Kaletra           | 100 mg / 25 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE)         |                           | 60 tablets                    |
| EU/1/01/172/007  | Kaletra           | 200 mg / 50 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE)         |                           | 360 (3 x 120) tablets         |
| EU/1/01/172/009  | Kaletra           | 80 mg/ml / 20 mg/ml | Oral solution         | Oral use                  | bottle (PET)          | 60 ml                     | 2 bottles + 2 x 2 ml syringes |